Laura Marin
@linguisticsnco
she/they. poetry & linguistics enthusiast. literature & linguistics student. queer anarchist. healing from cptsd.
ID: 1546784532619304962
12-07-2022 09:36:46
317 Tweet
76 Takipçi
314 Takip Edilen
Castor & Pollux7984 As a mutual acquaintance & colleague once said, "Ed-tech is a dumping ground for poorly designed software that doesn't work." Not surprising to hear that Teams has a foothold in this space.
An open letter to Johnson & Johnson. Stop pursuing the secondary patent of bedaquiline. YOU KNOW that millions of people will be unable to access lifesaving treatment for multidrug-resistant tuberculosis if you extend the patent. YOU KNOW it violates your credo. youtube.com/watch?v=tMhgw5…
Johnson & Johnson (@JNJGlobalHealth) is unjustly extending a patent on a life-saving tuberculosis drug. Today's the day for them to realize denying MDR-TB patients treatment is not worth the harm they're causing to core brands like Tylenol and Neutrogena. youtube.com/watch?v=tMhgw5…
If you believe Johnson and Johnson @JNJGlobalHealth Johnson & Johnson evergreening their patent on bedaquiline, denying millions of HUMAN BEINGS access to life saving medical care, is a violation of their corporate credo, please voice your concern here. secure.ethicspoint.com/domain/media/e…
An important message from John Green re: Johnson & Johnson's pursuit of the secondary patent of bedaquiline, which would result in an estimated 6 million people not being able to afford this treatment. Johnson & Johnson @JNJGlobalHealth we must put people over profits.
Good afternoon, Johnson & Johnson and @JNJGlobalHealth. We have reached the meme point of the campaign to get you to stop trying to evergreen bedaquiline.
Right, Johnson & Johnson? Right?
hahahahhaah thanks for the ad revenue, Johnson & Johnson. And thanks for the link to your excellent credo, which begins--I am quoting directly here--"We believe our first responsibility is to the patients." Stop pursuing an evergreen patent on bedaquiline now. #PatientsNotPatents
In just 22 hours, 578,000 people have watched this video about Johnson & Johnson's pursuit of secondary patents for bedaquiline and how this will lead to millions being unable to receive curative treatment for tuberculosis. youtu.be/tMhgw5SW0h4 #PatientsNotPatents Johnson & Johnson